It was mentioned there are four in testing and even more but Leronlimab was the only one talked about and brought up by name with the company noted as well.
In any case, check out company names CytoDyn is in the runing with yet again this morning on Benzinga (actually written yesterday after hours and posted today on TD Ameritrade and other sites):
HOW THE COVID PANDEMIC COULD END
Tyree Gorges , Benzinga Staff Writer FOLLOW
April 20, 2020 4:33pm 4 min read Comments
How The COVID-19 Pandemic Could End
The social distancing guidelines put in place to help slow the spread of the coronavirus have people growing restless and wondering when the end date will be for what is hopefully a once-in-a-lifetime pandemic. Here is a look how and when that could potentially happen.
Looking At The H1N1 Example
Every virus is different: they vary in complexity, the way they spread and how they react.
The last major pandemic was the 2009 H1N1 pandemic, also known as the swine flu. The first case occurred in April 2009 and the swine flu was officially declared a pandemic in June 2009.
The WHO declared the end of the pandemic in August 2010; the pandemic lasted roughly 15 months. It’s important to note that months before the pandemic was officially declared to be over, the government approved and began issuing vaccines.
COVID-19 Vaccines In The Works
It’s been made clear that COVID-19 can only truly be beaten by a vaccine, and the race to develop one took off as it became clear the coronavirus would take a foothold in the world.
Multiple biotech companies have trials in the works, but vaccines take months, if not years, to be approved and administered.
Benzinga Now Has FREE Trading Courses!
Need to brush up on your trading skills? Want to learn how to use the power of futures? Check out our free educational videos then test your expertise with our free quizzes.
Start learning now!
“A vaccine is not going to help us now, the next month or the month after,” Dr. Anthony Fauci, the director of the National Institute for Allergy and Infectious Diseases, said at a March White House task force briefing.
Although a vaccine can’t offer immediate help, it’s still needed, as it is believed the virus may cycle back after the initial outbreak.
“There’s a couple of handfuls of vaccines at different stages of development, but they're all following the same course,” Fauci said during the same briefing. Every drug has to go through the the FDA's three phases of clinical trials:
Phase 1 - The purpose of this clinical phase is to test the safety and dosage of a drug. This phase includes 20 to 100 healthy participants or people with the disease. This phase takes several months. Roughly 70% of drugs move to the next phase.
Phase 2 - The purpose of this phase is to test efficacy and side effects. This phase contains up to several hundred people with the disease and can last for several months to two years. Approximately 33% of drugs move to the next phase.
Phase 3 - The purpose of this phase is to test for efficacy and monitor any adverse reactions. This phase contains 300 to 3,000 participants that have the disease and can last from one to four years. Approximately 25-30% of drugs move to the next phase.
If the drug actually does work, Fauci said he hopes to rush development so it will have an impact during the next cycle.
This could be a time frame of anywhere between 12 and 18 months.
There are three vaccine candidates in the clinical testing phase, according to the WHO.
CanSino Biological, in development with the Beijing Institute of Biotechnology, has a vaccine candidate in Phase 2 and another in Phase 1.
Inovio Pharmaceuticals
INO 7.13%
has a vaccine candidate in Phase 1, and Moderna
MRNA 1.92%
also has one in development with the NIAID.
More than 60 other companies have a vaccine candidate, including Pfizer
PFE 1.57%, Gilead GILD 2.24%, Dynavax Technologies DVAX 3.92%, CytoDyn CYDY 3.5%, GlaxoSmithKline GSK 0.79%, Johnson & Johnson JNJ 2%, Novavax NVAX 1.97%, Vaxart VXRT 21.52%, Vir Biotechnology VIR 0.98% and more.
In any case, check out company names CytoDyn is in the runing with yet again this morning on Benzinga (actually written yesterday after hours and posted today on TD Ameritrade and other sites):
HOW THE COVID PANDEMIC COULD END
Tyree Gorges , Benzinga Staff Writer FOLLOW
April 20, 2020 4:33pm 4 min read Comments
How The COVID-19 Pandemic Could End
The social distancing guidelines put in place to help slow the spread of the coronavirus have people growing restless and wondering when the end date will be for what is hopefully a once-in-a-lifetime pandemic. Here is a look how and when that could potentially happen.
Looking At The H1N1 Example
Every virus is different: they vary in complexity, the way they spread and how they react.
The last major pandemic was the 2009 H1N1 pandemic, also known as the swine flu. The first case occurred in April 2009 and the swine flu was officially declared a pandemic in June 2009.
The WHO declared the end of the pandemic in August 2010; the pandemic lasted roughly 15 months. It’s important to note that months before the pandemic was officially declared to be over, the government approved and began issuing vaccines.
COVID-19 Vaccines In The Works
It’s been made clear that COVID-19 can only truly be beaten by a vaccine, and the race to develop one took off as it became clear the coronavirus would take a foothold in the world.
Multiple biotech companies have trials in the works, but vaccines take months, if not years, to be approved and administered.
Benzinga Now Has FREE Trading Courses!
Need to brush up on your trading skills? Want to learn how to use the power of futures? Check out our free educational videos then test your expertise with our free quizzes.
Start learning now!
“A vaccine is not going to help us now, the next month or the month after,” Dr. Anthony Fauci, the director of the National Institute for Allergy and Infectious Diseases, said at a March White House task force briefing.
Although a vaccine can’t offer immediate help, it’s still needed, as it is believed the virus may cycle back after the initial outbreak.
“There’s a couple of handfuls of vaccines at different stages of development, but they're all following the same course,” Fauci said during the same briefing. Every drug has to go through the the FDA's three phases of clinical trials:
Phase 1 - The purpose of this clinical phase is to test the safety and dosage of a drug. This phase includes 20 to 100 healthy participants or people with the disease. This phase takes several months. Roughly 70% of drugs move to the next phase.
Phase 2 - The purpose of this phase is to test efficacy and side effects. This phase contains up to several hundred people with the disease and can last for several months to two years. Approximately 33% of drugs move to the next phase.
Phase 3 - The purpose of this phase is to test for efficacy and monitor any adverse reactions. This phase contains 300 to 3,000 participants that have the disease and can last from one to four years. Approximately 25-30% of drugs move to the next phase.
If the drug actually does work, Fauci said he hopes to rush development so it will have an impact during the next cycle.
This could be a time frame of anywhere between 12 and 18 months.
There are three vaccine candidates in the clinical testing phase, according to the WHO.
CanSino Biological, in development with the Beijing Institute of Biotechnology, has a vaccine candidate in Phase 2 and another in Phase 1.
Inovio Pharmaceuticals
INO 7.13%
has a vaccine candidate in Phase 1, and Moderna
MRNA 1.92%
also has one in development with the NIAID.
More than 60 other companies have a vaccine candidate, including Pfizer
PFE 1.57%, Gilead GILD 2.24%, Dynavax Technologies DVAX 3.92%, CytoDyn CYDY 3.5%, GlaxoSmithKline GSK 0.79%, Johnson & Johnson JNJ 2%, Novavax NVAX 1.97%, Vaxart VXRT 21.52%, Vir Biotechnology VIR 0.98% and more.
